Exscientia is applying AI and big data processing to accelerate drug discovery and development.
Exscientia has raised €119M across 3 funding rounds from 2 investors, most recently a round in Sep 2021. Based in Oxford, UK; founded 2012; active in AI and Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-09-09 | Other | €41M | Gates Foundation | View deal → |
| 2020-05-25 | Series C | €55M | Novo Holdings | View deal → |
| 2019-01-01 | Series B | €23M | — | View deal → |
